Materia Malta, a subsidiary of medical cannabis producer and distributor Materia, has just completed its first export of commercial medical cannabis from its EU GMP manufacturing site.
This milestone represents the launch of Materia’s own brand and manufactured products into Germany – Europe’s largest medical cannabis market.
Materia’s German distribution subsidiary, Materia Deutschland GmbH, which took delivery of the shipment, has commenced sales to pharmacies with a number of pre-orders already received.
“Our products are already helping patients in Malta improve their quality of life, and now we can support the needs of patients in Germany too,” Nick Pateras, Materia Managing Director for Europe said.
“We believe Malta will play an important role in the global cannabis supply chain, as it has done with the broader pharmaceuticals sector for decades. We are proud to be the company establishing new frontiers for Malta and Europe’s cannabis industries,” he continued.
The company noted that it became ‘the first’ Malta-based manufacturer of medical cannabis to export product for commercial sale in another country, with previous exports having only been approved for research and development or lab testing purposes.
‘2025 is the year we reprioritise’ – Jonathan Dalli, Founder & CEO, Concept Stadium
'This year, we want to return to where it all started.'
George Kakouras appointed CEO of Harvest Technology plc
He has held various senior leadership positions within the technology and gaming sectors.
‘We are striving to raise awareness on national low fertility rate issue’ – Malta Employers’ President
Ivan Refalo also adds that another challenge faced by local employers is the increase of mental-health issues among their employees.
Hatten M&A Advisory expands global network with strategic International Partner appointments
The company has announced the appointment of two new international partners.
